Ausgabe 3/2011
Inhalt (26 Artikel)
Competing for patients: an ethical framework for recruiting patients with brain tumors into clinical trials
George M. Ibrahim, Caroline Chung, Mark Bernstein
Tissue concentration of systemically administered antineoplastic agents in human brain tumors
Marshall W. Pitz, Arati Desai, Stuart A. Grossman, Jaishri O. Blakeley
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review
Roger Henriksson, Thomas Asklund, Hans Skovgaard Poulsen
MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
Fateme Salehi, Bernd W. Scheithauer, Johann M. Kros, Queenie Lau, Michael Fealey, Dana Erickson, Kalman Kovacs, Eva Horvath, Ricardo V. Lloyd
Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma
Ning Bu, Haiqin Wu, Bingzhong Sun, Guilian Zhang, Shuqin Zhan, Ru Zhang, Le Zhou
Noninvasive monitoring of tumor growth in a rat glioma model: comparison between neurological assessment and animal imaging
Ting-Chung Wang, Ing-Tsung Hsiao, Yu-Kai Cheng, Shiaw-Pyng Wey, Tzu-Chen Yen, Kun-Ju Lin
Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway
M. Anand, T. E. Van Meter, H. L. Fillmore
Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells
M. Lorger, H. Lee, J. S. Forsyth, B. Felding-Habermann
Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells
Hiroyuki Uchida, Kazunori Arita, Shunji Yunoue, Hajime Yonezawa, Yoshinari Shinsato, Hiroto Kawano, Hirofumi Hirano, Ryosuke Hanaya, Hiroshi Tokimura
Reversible upregulation of tropomyosin-related kinase receptor B by geranylgeranoic acid in human neuroblastoma SH-SY5Y cells
Chiharu Sakane, Yoshihiro Shidoji
The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo
Muhannad Alkassar, Barbara Gärtner, Klaus Roemer, Friedrich Graesser, Jean Rommelaere, Lars Kaestner, Isabelle Haeckel, Norbert Graf
HMGN5: a potential oncogene in gliomas
Jintao Qu, Runmin Yan, Juxiang Chen, Tao Xu, Jingxu Zhou, Mei Wang, Chao Chen, Yong Yan, Yicheng Lu
Identifying the needs of brain tumor patients and their caregivers
Rupa Parvataneni, Mei-Yin Polley, Teresa Freeman, Kathleen Lamborn, Michael Prados, Nicholas Butowski, Raymond Liu, Jennifer Clarke, Margaretta Page, Jane Rabbitt, Anne Fedoroff, Emelia Clow, Emily Hsieh, Valerie Kivett, Rebecca DeBoer, Susan Chang
Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy
Ji Yeon Baek, Myoung Hee Kang, Yong Sang Hong, Tae Won Kim, Dae Yong Kim, Jae Hwan Oh, Seung Hoon Lee, Jin Hong Park, Jong Hoon Kim, Sun Young Kim
Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults
E. H. Nielsen, U. Feldt-Rasmussen, L. Poulsgaard, L. Ø. Kristensen, J. Astrup, J. O. Jørgensen, P. Bjerre, M. Andersen, C. Andersen, J. Jørgensen, J. Lindholm, P. Laurberg
Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series
Marc C. Chamberlain, Sandra K. Johnston
Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution’s experience
Laura Negretti, Karim Bouchireb, Christine Levy-Piedbois, Jean Louis Habrand, Frederic Dhermain, Chantal Kalifa, Jacques Grill, Christelle Dufour
Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors
Tomohiro Kawaguchi, Toshihiro Kumabe, Masayuki Kanamori, Ryuta Saito, Yoji Yamashita, Yukihiko Sonoda, Mika Watanabe, Teiji Tominaga
Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort
S. C. Erridge, M. G. Hart, G. R. Kerr, C. Smith, S. McNamara, R. Grant, A. Gregor, I. R. Whittle
Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05)
Oliver Grauer, Christina Pascher, Christian Hartmann, Florian Zeman, Michael Weller, Martin Proescholdt, Alexander Brawanski, Thorsten Pietsch, Wolfgang Wick, Ulrich Bogdahn, Peter Hau
Leptomeningeal disease in oligodendroglial tumors: a population-based study
Gloria Roldán, Jennifer Chan, Misha Eliasziw, J. Gregory Cairncross, Peter A. Forsyth
Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer
Nicholas F. Marko, John H. Suh, Sam T. Chao, Gene H. Barnett, Michael A. Vogelbaum, Steven Toms, Robert J. Weil, Lilyana Angelov
Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma
Moo-Kon Song, Joo-Seop Chung, Young-Don Joo, Sang-Min Lee, Sung-Yong Oh, Dong-Hoon Shin, Eun-Young Yun, Seung-Geun Kim, Young-Mi Seol, Ho-Jin Shin, Young-Jin Choi, Goon-Jae Cho
Erratum to: Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma
Moo-Kon Song, Joo-Seop Chung, Young-Don Joo, Sang-Min Lee, Sung-Yong Oh, Dong-Hoon Shin, Eun-Young Yun, Seung-Geun Kim, Young-Mi Seol, Ho-Jin Shin, Young-Jin Choi, Goon-Jae Cho
Primary leptomeningeal plasmablastic lymphoma
Marlon S. Mathews, Daniela A. Bota, Ronald C. Kim, Anton N. Hasso, Mark E. Linskey
Primary cerebellar myxopapillary ependymoma
Konstantinos Margetis, Christos Koutsarnakis, George Stranjalis